(AMRX) |
| 0 (0%) 11-03 08:02 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 25.32 |
| Resistance 1: | 21.68 |
| Pivot price: | 20.27 |
| Support 1: | 19.89 |
| Support 2: | 18.78 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.490 |
| Book Value | 0.100 |
| PEG Ratio | 1.93 |
| Gross Profit | 3.560 |
| Profit Margin (%) | 5.05 |
| Operating Margin (%) | 18.33 |
| Return on Assets (ttm) | 8.6 |
| Return on Equity (ttm) | 613.0 |
Company news
Tue, 03 Nov 2026
Amneal Pharmaceuticals earnings beat by $0.03, revenue topped estimates - Investing.com
Tue, 03 Nov 2026
Amneal: Q3 Earnings Snapshot - kens5.com
Tue, 03 Nov 2026
Amneal (NASDAQ:AMRX) beats expectations in strong Q3 2026, full-year outlook slightly exceeds expectations - StockStory
Tue, 03 Nov 2026
AMNEAL PHARMACEUTICALS ($AMRX) Releases Q3 2026 Earnings - Quiver Quantitative
Tue, 03 Nov 2026
Amneal (NASDAQ:AMRX) beats expectations in strong Q3 2026, full-year outlook slightly exceeds expectations - Yahoo Finance
Tue, 03 Nov 2026
Amneal Pharmaceuticals (AMRX) Tops Q3 EPS by 3c; Offers Guidance - StreetInsider
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
